Mumbai, Maharashtra
GST No. 27AAICT4656Q1ZG
Approx. Rs 1,000 / StripeGet Latest Price
Product BrochureProduct Details:| Strength | 100 mg |
| Form | Capsule |
| Pack Type | Box |
| Packaging Size | 3 Strips of 10 Tablets per box |
| Brand | Nintenib |
| Manufactured By | BDR |
Approx. Rs 2,000 / BottleGet Latest Price
Product BrochureProduct Details:| Strength | 70 mg |
| Pack Size | 1*60 Tablet |
| Brand Name | Dasakast |
| Manufacturer | Aprazer |
| Treatment | Blood Cancer |
| Form | Tablet |
Approx. Rs 15,000 / BoxGet Latest Price
Product BrochureProduct Details:| Strength | 100 mg |
| Pack Size | 60 Capsule |
| Pack Type | Box |
| Brand | Cyendiv |
| Manufacturer | Boehringer Ingelheim |
| Form | Capsule |
Approx. Rs 2,000 / BottleGet Latest Price
Product BrochureProduct Details:| Strength | 150 mg |
| Pack Size | 1*30 Tablet |
| Pack Type | Box |
| Brand Name | Zyceva |
| Manufacturer | Zydus |
| Country of Origin | Made in India |
| Type | Finished |
| Medicine Type | Allopathic |
Approx. Rs 2,000 / BottleGet Latest Price
Product BrochureProduct Details:| Strength | 150 mg |
| Pack Size | 1*30 Tablet |
| Pack Type | Strips |
| Brand Name | Erlonat |
| Manufacturer | Natco |
| Country of Origin | Made in India |
| Medicine Type | Allopathic |
| Product Type | Finished |
Approx. Rs 2,000 / StripeGet Latest Price
Product BrochureProduct Details:| Strength | 10 mg |
| Drug Name | Evertor |
| Generic Name | Everolimus |
| Country of Origin | Made in India |
| Product Type | Finished |
| Medicine Type | Allopathic |
| Size | Box |
Approx. Rs 2,000 / BoxGet Latest Price
Product BrochureProduct Details:| Strength | 100 mg |
| Form | Capsules |
| Pack Type | Box |
| Pack Size | 30 Capsule |
| Barnd | Nintib |
| Manufacturer | Cipla |
Approx. Rs 2,000 / BottleGet Latest Price
Product BrochureProduct Details:| Strength | 50 mg |
| Pack Size | 1*60 Tablet |
| Pack Type | Box |
| Brand Name | Dasanat |
| Manufacturer | Natco Pharma Ltd |
| Composition | Dasatinib |
| Treatment | Blood cancer |
Approx. Rs 2,000 / BottleGet Latest Price
Product BrochureProduct Details:| Dose/Strength | 400 mg |
| Manufactured By | Hetero Healthcare Ltd. |
| Brand | Pazinib |
| Packaging Size | 30 Capsule |
| Composition | Pazopanib 400mg |
| Treatment | Renal Cell Carcinoma |
Approx. Rs 2,000 / BottleGet Latest Price
Product BrochureProduct Details:| Strength | 70 mg |
| Pack Size | 1*60 Tablet |
| Pack Type | Box |
| Brand Name | Sprycel |
| Manufacturer | BMS India Pvt Ltd |
| Treatment | Blood cancer |
| Composition | Dasatinib |
Approx. Rs 2,000 / BoxGet Latest Price
Product BrochureProduct Details:| Strength | 200 mg |
| Form | Capsule |
| Pack Size | 28 Capsule |
| Pack Type | Box |
| Brand | Tasigna |
| Composition | Nilotinib |
| Manufacturer | Novartis |
| Treatment | Chronic Myeloid Leukemia |
Approx. Rs 2,000 / BottleGet Latest Price
Product BrochureProduct Details:| Strength | 70 mg |
| Pack Size | 1*60 Tablet |
| Pack Type | Box |
| Brand Name | Dyronib |
| Manufacturer | Hetero Healthcare Limited |
| Treatment | Blood cancer |
Approx. Rs 2,000 / BottleGet Latest Price
Product BrochureProduct Details:| Strength | 70 mg |
| Pack Size | 1*60 Tablet |
| Pack Type | Box |
| Brand Name | Dasatrue |
| Manufacturer | Cipla |
| Treatment | Blood cancer |
| Form | Tablet |
Approx. Rs 2,000 / BottleGet Latest Price
Product BrochureProduct Details:| Strength | 150 mg |
| Pack Size | 1*30 Tablet |
| Pack Type | Box |
| Brand Name | Erlocip |
| Manufacturer | Cipla |
| Country of Origin | Made in India |
| Product Type | Finished |
| Medicine Type | Allopathic |
Approx. Rs 2,000 / BottleGet Latest Price
Product BrochureProduct Details:| Strength | 20 mg |
| Pack Size | 1*60 Tablet |
| Pack Type | Box |
| Brand Name | Dasasheel |
| Manufacturer | Shilpa Medicare |
| Treatment | Blood Cancer |
| Form | Tablet |
Approx. Rs 2,000 / BoxGet Latest Price
Product BrochureProduct Details:| Strength | 40 mg |
| Pack Size | 4x7x4 |
| Form | Capsule |
| Pack Type | Box |
| Brand | Capmide |
| Treatment | Prostate cancer |
Approx. Rs 1,000 / PieceGet Latest Price
Product BrochureProduct Details:| Dose/Strength | 4 mg |
| Packaging Type | Vial |
| Manufacturer | Natco |
| Usage/Application | Hospital |
| Brand Name | Zoldonat |
| Form of Medicine | Injection |
Approx. Rs 1,500 / BottleGet Latest Price
Product BrochureProduct Details:| Strength | 150 mg |
| Pack Size | 1*30 Tablet |
| Brand Name | Erlonat |
| Manufacturer | Natco |
| Usages | Hospital |
| Packaging Type | Bottle |
Approx. Rs 2,000 / BottleGet Latest Price
Product BrochureProduct Details:| Strength | 70 mg |
| Pack Size | 1*60 Tablet |
| Pack Type | Box |
| Brand Name | Dasakast |
| Manufacturer | Aprazer Heathcare |
| Treatment | Blood cancer |
| Composition | Dasatinib |
Dasakast (dasatinib 70mg) is an oral drug indicated for patients suffering from blood cancer in both adults and children. Specifically, dasakast 50 mg (dasatinib) is used in adults with Chronic myeloid leukemia (CML) in a long-lasting (chronic) phase of the disease. Dasatinib belongs to the class of medicine known as kinase inhibitors that works its action by:
Dasatinib, with the above actions, finally disrupts the spread of CML cancer cells.
Administration of Dasakast 50 mg (Dasatinib):
Dasakast (dasatinib) is given in the form of 100 mg dose (2×50 mg tablets) once daily. However, if the condition of patients does not improve, the dose is escalated to 140 mg (2×100 mg tablets) once daily. It can be taken with or without food in the morning or evening. Once swallowed, dasatinib is completely absorbed (bio-available) in 6 hours and is distributed throughout the region of cancer. It is metabolized in liver by different types of proteins and subsequently after completing its action, more than 50% of dasatinib is expelled from the body within 3 to 5 hours.
When should Dasakast 50 mg (Dasatinib) be avoided or used cautiously:
Most common side-effects of Dasakast 50 mg (Dasatinib):
The uncommon ones are:
Approx. Rs 2,000 / StripeGet Latest Price
Product BrochureProduct Details:| Strength | 400 mg |
| Size | 3x10 |
| Brand | Veenat |
| Product Type | Finished |
| manufacturer | Natco |
| Type | Box |
| Form | Tablet |
Approx. Rs 2,000 / StripeGet Latest Price
Product BrochureProduct Details:| Strength | 10 mg |
| Drug Name | Evermil |
| Country of Origin | Made in India |
| Form | Tablets |
| Size | Box |
| Medicine Type | Allopathic |
| Product Type | Finished |
Approx. Rs 2,000 / BottleGet Latest Price
Product BrochureProduct Details:| Strength | 70 mg |
| Pack Size | 1*60 Tablet |
| Pack Type | Box |
| Brand Name | Spnib |
| Manufacturer | Zydus Cadila Healthcare Ltd |
| Treatment | Blood cancer |
Approx. Rs 2,000 / BoxGet Latest Price
Product BrochureProduct Details:| Strength | 150 mg |
| Brand | Nindanib |
| Manufacturer | Glenmark |
| Product Type | Finished |
| Medicine Type | Allopathic |
| Dosage | 150 mg |
| Packaging Type | Strip |
| Size | Box |
Approx. Rs 4,283.17 / VialGet Latest Price
Product BrochureProduct Details:| Minimum Order Quantity | 1 Vial |
| Strength | 100 mg |
| Form of Medicine | Solution |
| Brand | Xpreza |
| Packaging Type | Bottle |
| Shelf Life | 24 Months |
Azacitidine for injection is a DNA methylation inhibitor used to treat myelodysplastic syndromes and acute myeloid leukemia. Administered subcutaneously or intravenously, it reactivates tumor-suppressor genes, restores normal blood cell development, and delays disease progression, offering targeted, disease-modifying therapy with significant survival benefits.
Approx. Rs 2,000 / BottleGet Latest Price
Product BrochureProduct Details:| Strength | 140 mg |
| Pack Type | Box |
| Pack Size | 30 Capsule |
| Brand | Ibrunat |
| Manufacturer | Natco Pharma Ltd. |
| Treatment | Blood cancer |
| Form | Capsule |
Ibrunat (Ibrutinib 140mg)contains the Drug/Molecule called “Ibrutinib”. Ibrunat is a small molecule drug that is used to bind permanently to a protein called “Bruton’s tyrosine kinase (BTK)” which is important in B cells.
How Ibrunat Ibrutinib 140 mg Capsule Works
Bruton’s tyrosine kinase is a protein that is found in your B cells and it sends “signals” to the other parts of the body that help B cells to survive and multiply.
But these generic ibrunat capsules block BTK & help in killing and reducing the number of cancerous B-cells. Therefore, this stops or slows the progression of cancer.
Moreover, it also depends on “how the patient’s body reacts to the first dose.” The Natco Ibrunat Capsules should be taken orally with a glass of water. Please remember to not to open, crush, or chew the capsules.
There are chances of occurring the new cancers in people taking Ibrunat, including skin cancer & other cancers.
The most common side effects may include:
Interactions with other drugs
Overdose
Precaution
The patients taking ibrunat shouldn’t take it with grapefruit or Seville oranges. Which includes eating these fruits, drinking the juice, or taking the supplements that mat contain these fruits. It is prescribed not to take these fruits because these can increase the amount of Ibrunat in blood
Approx. Rs 2,000 / BottleGet Latest Price
Product BrochureProduct Details:| Strength | 140 mg |
| Pack Type | Bottle |
| Pack Size | 120 Capsule |
| Form | Capsule |
| Brand | Ibrushil |
| Manufacturer | Shilpa Medicare Ltd |
| Treatment | Blood Cancer |
Approx. Rs 2,000 / BottleGet Latest Price
Product BrochureProduct Details:| Dose/Strength | 400 mg |
| Manufactured By | Gsk |
| Country of Origin | Made in India |
| Brand | Votrient |
| Product Type | Finished |
| Medicine Type | Allopathic |
| Storage | keep in Cool Dry Place |
Approx. Rs 2,000 / BottleGet Latest Price
Product BrochureProduct Details:| Dose/Strength | 300 mg |
| Packaging Size | 1x30Tablets |
| Packaging Type | Blister |
| Manufacturer | Mylan |
| Shelf Life | 24 Month |
| Usage / Application | Clinical |
| Product Type | Finished |
| Medicine Type | Allopathic |
Approx. Rs 2,000 / BottleGet Latest Price
Product BrochureProduct Details:| Strength | 70 mg |
| Pack Size | 1*30 Tablet |
| Pack Type | Box |
| Brand Name | Invista |
| Manufacturer | Dr Reddy's Laboratories Ltd |
| Treatment | Blood cancer |
Product Price :Get Latest Price
Product BrochureProduct Details:| Strength | 60 mg |
| Brand | Erleada |
| Manufacturer | Janssen |
| Product Type | Finished |
| Medicine Type | Allopathic |
| Storage | keep in Cool Dry Place |
| Size | Box |
Approx. Rs 2,000 / BottleGet Latest Price
Product BrochureProduct Details:| Strength | 100 mg |
| Pack Size | 1*30 Tablet |
| Pack Type | Box |
| Brand Name | Tarceva |
| Country of Origin | Made in India |
| Product Type | Finished |
| Medicine Type | Allopathic |
Approx. Rs 1,000 / VialGet Latest Price
Product BrochureProduct Details:| Strength | 100 mg |
| Manufacturer | Mylan |
| Composition | Azacitidine |
| Form | Injection |
| Brand | Myaza |
| Category | Myelodysplastic Syndrome |
Approx. Rs 8,000 / BottleGet Latest Price
Product BrochureProduct Details:| Strength | 200 mg |
| Pack Type | Bottle |
| Packaging Size | 120 Tablet |
| Brand | Soranib |
| Manufacturer | Cipla |
| Treatment | Liver cancer |
Approx. Rs 8,000 / BottleGet Latest Price
Product BrochureProduct Details:| Strength | 100 mg |
| Pack Size | 120 Tablet |
| Pack Type | Bottle |
| Form | Tablet |
| Brand | Sorafenat |
| Manufacturer | Natco Pharma Ltd |
Approx. Rs 1,000 / BoxGet Latest Price
Product BrochureProduct Details:| Strength | 1 mg |
| Packaging Type | Box |
| Composition | Varenicline Tartrate 1 mg |
| Brand | Varenismart 1mg |
| Form | Tablet |
| Manufacturer | Healing Pharma India Pvt. Ltd. |
| Pack Size | 1x10 |
Varenicline (trade name Chantix and Champix) is a medication used for smoking cessation. Varenicline is also used for the treatment of dry eye disease.
The most common side-effects include nausea (feeling sick), insomnia (difficulty sleeping), abnormal dreams, headache and nasopharyngitis (inflammation of the nose and throat).
It is a high-affinity partial agonist for nAChRα4β2, a subtype of nicotinic acetylcholine receptor (nAChR) that leads to the release of the neurotransmitter dopamine in the nucleus accumbens (reward center of the brain) when activated, and therefore, has the capacity to reduce the feelings of craving and withdrawal caused by smoking cessation. In this respect it is similar to cytisine and different from the nicotinic antagonist bupropion and nicotine replacement therapies (NRTs) like nicotine patches and nicotine gum. It is estimated that varenicline successfully helps one of every eleven people who smoke remain abstinent from tobacco at six months.
It is on the World Health Organization's List of Essential Medicines. It is available as a generic medication. In 2020, it was the 275th most commonly prescribed medication in the United States, with more than 1 million prescriptions
Approx. Rs 2,000 / BoxGet Latest Price
Product BrochureProduct Details:| Strength | 40 mg |
| Brand | Xtandi |
| Composition | Enzalutamide |
| Packaging Type | Box |
| Packaging Size | 112 Capsules |
| Form | Capsules |
Approx. Rs 3,850 / BoxGet Latest Price
Product BrochureProduct Details:| Dose/Strength | 250 mg |
| Usage/Application | Hospital |
| Manufacturer | Natco |
| Packaging Type | Box |
| Form | Tablet |
| Treatment | Non-small cell lung cancer |
| Pack Size | 30 Tablet |
Approx. Rs 2,000 / VialGet Latest Price
Product BrochureProduct Details:| Dose/Strength | 2 mg |
| Packaging Type | Box |
| Manufactured By | Mylon |
| Usage/Application | Clinical |
| Shelf life | 24 Month |
| Medicine Type | Allopathic |
| Product Type | Finished |
Approx. Rs 2,000 / BottleGet Latest Price
Product BrochureProduct Details:| Strength | 250 mg |
| Manufactured By | Mylan |
| Generic name | Herlapsa |
| Packing | Box |
| Country of Origin | Made in India |
| Form | Tablet |
| Usage | Clinical |
Approx. Rs 2,000 / BottleGet Latest Price
Product BrochureProduct Details:| Strength | 250 mg |
| Manufactured By | Cipla |
| Generic name | Combinib |
| Packing | Box |
| Country of Origin | Made in India |
| Size | 30 Tablet |
| Product Type | Finished |
| Medicine Type | Allopathic |
Combinib (Lapatinib 250 mg) in combination with capecitabine, is indicated for the treatments of the patients with advanced or metastatic breast cancer whose tumor overexpress HER2+/neu (ErbB2) and who have received prior therapy including trastuzumab.
In combination with letrozole for the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer that overexpresses the HER2 receptor for whom hormonal therapy is indicated.
Lapatinib in combination with trastuzumab, indicated for the treatment of the patients with hormone receptor-negative metastatic breast cancer whose tumours overexpress HER2/neu(ErbB2) and who have progressed on prior trastuzumab therapy in combination with chemotherapy in the metastatic setting.
Dose & Method of Administration:HER2(ErbB2) overexpressing tumours are defined by IHC3+, or IHC2+ with gene amplification or gene amplification alone. HER2 status should be determined using accurate and validated methods.
PosologyThe recommended dose of Lapatinib is 1250 mg (i.e. five tablets) once daily continuously.
The recommended dose of capecitabine is 2000 mg/m2/day taken in 2 dose 12 hours apart on days 1-14 in a 21 day cycle. Capecitabine should be taken with food or within 30 minutes after food. Please refer to the full prescribing information of capecitabine.
Lapatinib/trastuzumab Combination Posology:
The recommended dose of Lapatinib is 1250mg (i.e. four tablets) once daily continuously.
The recommended dose of trastuzumab is 4 mg/kg administered as an intravenous (IV) loading dose, followed by 2 mg/kg IV weekly. Please refer to the full prescribing information of trastuzumab.
Lapatinib/Aromatase Inhibitor Combination Posology:
The recommended dose of Lapatinib is 1500mg (i.e. six tablets) once daily continuously.
Please refer to the full prescribing information of the co-administered aromatase inhibitor for dosing details.
Dose Delay and Dose ReductionCardiac Events:
Lapatinib should be discontinued in patients with symptoms associated with decreased left ventricular ejection fraction (LVEF)that are National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) grade 3 or greater or if there LVEF drops below the institutions lower limit of normal. Lapatinib may be restarted at a reduce dose (750 mg/day when administered with trastuzumab,1000 mg/day when administered with capecitabine or 1250 mg/day when administered with an aromatase inhibitor) after a minimum of 2 weeks and if the LVEF recovers to the normal and the patient is asymptomatic.
Interstitial Lung Disease/Pneumonitis:
Lapatinib should be discontinued in patients who experience pulmonary symptoms which are NCICTACAE grade 3 or greater.
Diarrhoea:
Lapatinib should be interrupted in patients with diarrhoea which is NCI CTCAE grade 3 or grade 1 or with 2 complicating features (moderate to serve abdominal cramping, nausea or vomiting greater than or equal to NCI CTCAE grade 2, decreased performance status, fever, sepsis, neutropenia, frank bleeding or dehydration). Lapatinib may be reintroduced at a lower dose (reduce from 1000mg/day to 750 mg/day, from 1250 mg/day to 1000mg/day or from 1500 mg/day to 1250 mg/day) when diarrhoea resolves to grade 1 or less. Lapatinib dosing should be permanently discontinued in patients with diarrhoea which is NIC CTCAE grade4.
Other Toxicities:
Discontinuation or interruption of dosing with Lapatinib may be considered when a patient develop toxicity greater than or equal to grade 2 on the NCI CTCAE.
Explore More Products
© Toro Pharmaceuticals Private Limited. All Rights Reserved (Terms of Use)
Developed and Managed by IndiaMART InterMESH Limited